Abstract
Renal cell carcinoma (RCC) is one of the most important urologic malignancies with a continuously growing incidence and health economic relevance. In 2011, several hundred articles, abstracts, and lectures have been presented at the leading global urooncologic congresses. This review was composed to give an overview on the flood of novel findings dealing with diagnostics and therapy of both localized and advanced RCC. The most clinically relevant data are discussed in detail.
Highlights
Renal cell carcinoma (RCC) is one of the most important urologic malignancies with a continuously growing incidence and health economic relevance
Tsivian et al [4] from Durham presented a retrospective monocenter analysis of data they collected from 2000 to 2008 in 243 patients who had received a partial nephrectomy for a small solid renal tumor
The authors concluded that an active surveillance strategy can be justified for patients with tumors
Summary
Renal cell carcinoma (RCC) is one of the most important urologic malignancies with a continuously growing incidence and health economic relevance. Tsivian et al [4] from Durham presented a retrospective monocenter analysis of data they collected from 2000 to 2008 in 243 patients who had received a partial nephrectomy for a small solid renal tumor.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
